Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification ; volume:18 ; number:1 ; day:28 ; month:6 ; year:2016 ; pages:1-11 ; date:12.2016
Breast cancer research ; 18, Heft 1 (28.6.2016), 1-11, 12.2016
- Urheber
-
Allott, Emma H.
- Beteiligte Personen und Organisationen
-
Geradts, Joseph
Sun, Xuezheng
Cohen, Stephanie M.
Zirpoli, Gary R.
Khoury, Thaer
Bshara, Wiam
Chen, Mengjie
Sherman, Mark E.
Palmer, Julie R.
Ambrosone, Christine B.
Olshan, Andrew F.
Troester, Melissa A.
SpringerLink (Online service)
- DOI
-
10.1186/s13058-016-0725-1
- URN
-
urn:nbn:de:1111-2016062914868
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Allott, Emma H.
- Geradts, Joseph
- Sun, Xuezheng
- Cohen, Stephanie M.
- Zirpoli, Gary R.
- Khoury, Thaer
- Bshara, Wiam
- Chen, Mengjie
- Sherman, Mark E.
- Palmer, Julie R.
- Ambrosone, Christine B.
- Olshan, Andrew F.
- Troester, Melissa A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity impacts the response to anti-neu antibody therapy
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Discordance is the Key
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity impacts the response to anti-neu antibody therapy
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Discordance is the Key
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity impacts the response to anti-neu antibody therapy
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Discordance is the Key
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer